China NT Pharma Group Company Limited (HKG:1011)

HKG:1011 Revenue

In the year 2025, China NT Pharma Group Company had annual revenue of 24.16M CNY, down -36.36%. China NT Pharma Group Company had revenue of 12.16M in the half year ending December 31, 2025.

• Revenue: 24.16M CNY
• Revenue Growth: -36.36%
• P/S Ratio: 16.24
• Revenue / Employee: 1.10M CNY
• Employees: 22
• Market Cap: 436.54M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	24.16M	-13.80M	-36.36%
Dec 31, 2024	37.96M	30.59M	415.34%
Dec 31, 2023	7.37M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	226.70M	4.97M	2.24%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 18, 2026

Data Sources Report a data error